Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Journal of Psoriasis and Psoriatic Arthritis
|
September 19, 2024
Coverage of Specialty Drugs for Psoriasis and Psoriatic Arthritis by Commercial Insurance Companies
Christine Learned, Sara Alsukait, Kristin R Fiumara, et al.
International Journal of Technology Assessment in Health Care
|
January 12, 2016
CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY
James D Chambers, Matthew D Chenoweth, Junhee Pyo, et al.
Applied Health Economics and Health Policy
|
November 25, 2021
Are Medical Devices Cost-Effective?
James D Chambers, Madison C Silver, Flora C Berklein, et al.
The American Journal of Managed Care
|
October 18, 2019
Variation in US private health plans' coverage of orphan drugs
James D Chambers, Ari D Panzer, David D Kim, et al.
Health Affairs (Project Hope)
|
November 4, 2024
Small-Molecule Drugs Offer Comparable Health Benefits To Biologics At Lower Costs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Health Affairs (Project Hope)
|
November 5, 2019
Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage
James D Chambers, Ari D Panzer, Elle F Pope, et al.
Health Affairs Scholar
|
February 25, 2026
FDA approvals of specialty drugs, 2000-2024
Sophie E Knox, Claire H Brennan, Daniel E Enright, et al.
Health Affairs Scholar
|
July 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?
Molly T Beinfeld, Fariel LaMountain, Glenn Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan Drugs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Pharmacoepidemiology and Drug Safety
|
March 27, 2020
What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?
Ari D Panzer, Nikoletta M Margaretos, Rachel C Lai, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Journal of Psoriasis and Psoriatic Arthritis
|
September 19, 2024
Coverage of Specialty Drugs for Psoriasis and Psoriatic Arthritis by Commercial Insurance Companies
Christine Learned, Sara Alsukait, Kristin R Fiumara, et al.
International Journal of Technology Assessment in Health Care
|
January 12, 2016
CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY
James D Chambers, Matthew D Chenoweth, Junhee Pyo, et al.
Applied Health Economics and Health Policy
|
November 25, 2021
Are Medical Devices Cost-Effective?
James D Chambers, Madison C Silver, Flora C Berklein, et al.
The American Journal of Managed Care
|
October 18, 2019
Variation in US private health plans' coverage of orphan drugs
James D Chambers, Ari D Panzer, David D Kim, et al.
Health Affairs (Project Hope)
|
November 4, 2024
Small-Molecule Drugs Offer Comparable Health Benefits To Biologics At Lower Costs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Health Affairs (Project Hope)
|
November 5, 2019
Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage
James D Chambers, Ari D Panzer, Elle F Pope, et al.
Health Affairs Scholar
|
February 25, 2026
FDA approvals of specialty drugs, 2000-2024
Sophie E Knox, Claire H Brennan, Daniel E Enright, et al.
Health Affairs Scholar
|
July 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?
Molly T Beinfeld, Fariel LaMountain, Glenn Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan Drugs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Pharmacoepidemiology and Drug Safety
|
March 27, 2020
What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?
Ari D Panzer, Nikoletta M Margaretos, Rachel C Lai, et al.
Page
of 10